Search Results - "Ortiz Romero, Pablo L"

Refine Results
  1. 1

    The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma by Scarisbrick, Julia J., Bagot, Martine, OrtizRomero, Pablo L.

    Published in British journal of haematology (01-02-2021)
    “…Summary Cutaneous T‐cell lymphomas (CTCLs) have a chronic, relapsing course, and the most common subtypes are mycosis fungoides and Sézary syndrome. The…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Real‐life experience of using pegylated liposomal doxorubicin in primary cutaneous T‐cell lymphomas by Falkenhain‐López, Daniel, Puerta‐Peña, Mario, Fulgencio‐Barbarin, Jon, Sánchez‐Velázquez, Alba, Vico‐Alonso, Cristina, Postigo‐Llorente, Concepción, OrtizRomero, Pablo L.

    Published in Clinical and experimental dermatology (01-09-2022)
    “…Mycosis fungoides (MF) is the most prevalent subtype of primary cutaneous T‐cell lymphomas (CTCLs). Sézary syndrome (SS) is another entity defined by leukaemic…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma by Monsálvez, Veronica, Montes-Moreno, Santiago, Artiga, María J, Rodríguez, Maria E, Espiridión, Beatriz S, Lozano, Maria, Fernández-de-Misa, Ricardo, Rodríguez-Peralto, Jose L, Piris, Miguel A, Ortíz-Romero, Pablo L

    Published in Modern pathology (01-02-2013)
    “…Indolent primary cutaneous B-cell lymphoma is a group of malignant lymphomas comprising marginal zone B-cell lymphoma and centrofollicular B-cell lymphoma…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Mycosis fungoides progression could be regulated by microRNAs by Manso, Rebeca, Martínez-Magunacelaya, Nerea, Eraña-Tomás, Itziar, Monsalvez, Verónica, Rodríguez-Peralto, José L, Ortiz-Romero, Pablo-L, Santonja, Carlos, Cristóbal, Ion, Piris, Miguel A, Rodríguez-Pinilla, Socorro M

    Published in PloS one (12-06-2018)
    “…Differentiating early mycosis fungoides (MF) from inflammatory dermatitis is a challenge. We compare the differential expression profile of early-stage MF…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-Life Clinical Data by Amitay-Laish, I, Guenova, E, Ortiz-Romero, P, Vico-Alonso, C, Rozati, S, Geskin, L, Nikolaou, V, Papadavid, E, Barzilai, A, Pavlovsky, L, Didkovsky, E, Naveh, H, Akilov, O, Hodak, E

    Published in Acta dermato-venereologica (01-09-2020)
    “…Literature regarding the effect of biologics on the course of mycosis fungoides (MF) is scarce. This multicentre study analysed retrospective data on 19…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    DEK oncogene is overexpressed during melanoma progression by Riveiro‐Falkenbach, Erica, Ruano, Yolanda, García‐Martín, Rosa M., Lora, David, Cifdaloz, Metehan, Acquadro, Francesco, Ballestín, Claudio, OrtizRomero, Pablo L., Soengas, María S., Rodríguez‐Peralto, José L.

    Published in Pigment cell and melanoma research (01-03-2017)
    “…Summary DEK is an oncoprotein involved in a variety of cellular functions, such as DNA repair, replication, and transcriptional control. DEK is preferentially…”
    Get full text
    Journal Article